Evaluation of aortic arch calcification in type 2 diabetic patients

VASA ◽  
2005 ◽  
Vol 34 (2) ◽  
pp. 113-117 ◽  
Author(s):  
Papanas ◽  
Symeonidis ◽  
Maltezos ◽  
Giannakis ◽  
Mavridis ◽  
...  

Background: The purpose of this study is to evaluate the severity of aortic arch calcification among type 2 diabetic patients in association with diabetes duration, diabetic complications, coronary artery disease and presence of cardiovascular risk factors. Patients and methods: This study included 207 type 2 diabetic patients (101 men) with a mean age of 61.5 ± 8.1 years and a mean diabetes duration of 13.9 ± 6.4 years. Aortic arch calcification was assessed by means of posteroanterior chest X-rays. Severity of calcification was graded as follows: grade 0 (no visible calcification), grade 1 (small spots of calcification or single thin calcification of the aortic knob), grade 2 (one or more areas of thick calcification), grade 3 (circular calcification of the aortic knob). Results: Severity of calcification was grade 0 in 84 patients (40.58%), grade 1 in 64 patients (30.92%), grade 2 in 43 patients (20.77%) and grade 3 in 16 patients (7.73%). In simple regression analysis severity of aortic arch calcification was associated with age (p = 0.032), duration of diabetes (p = 0.026), insulin dependence (p = 0.042) and presence of coronary artery disease (p = 0.039), hypertension (p = 0.019), dyslipidaemia (p = 0.029), retinopathy (p = 0.012) and microalbuminuria (p = 0.01). In multiple regression analysis severity of aortic arch calcification was associated with age (p = 0.04), duration of diabetes (p = 0.032) and presence of hypertension (p = 0.024), dyslipidaemia (p = 0.031) and coronary artery disease (p = 0.04), while the association with retinopathy, microalbuminuria and insulin dependence was no longer significant. Conclusions: Severity of aortic arch calcification is associated with age, diabetes duration, diabetic complications (retinopathy, microalbuminuria), coronary artery disease, insulin dependence, and presence of hypertension and dyslipidaemia.

Author(s):  
J. Zavar-Reza ◽  
H. Shahmoradi ◽  
A. Mohammadyari ◽  
M. Mohammadbeigi ◽  
R. Hosseini ◽  
...  

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1425-P
Author(s):  
ATSUHIKO KAWABE ◽  
YUKI NAKATANI ◽  
SHOYA ONO ◽  
YASUSHI MIYASHITA ◽  
MIHOKO MATSUMURA ◽  
...  

2012 ◽  
Vol 164 (4) ◽  
pp. 600-606.e1 ◽  
Author(s):  
Jean-Guillaume Dillinger ◽  
Akram Drissa ◽  
Georgios Sideris ◽  
Claire Bal dit Sollier ◽  
Sebastian Voicu ◽  
...  

Immunobiology ◽  
2017 ◽  
Vol 222 (10) ◽  
pp. 960-966 ◽  
Author(s):  
Rosalinda Posadas-Sánchez ◽  
Ángel René López-Uribe ◽  
Carlos Posadas-Romero ◽  
Nonanzit Pérez-Hernández ◽  
José Manuel Rodríguez-Pérez ◽  
...  

Diabetes Care ◽  
2002 ◽  
Vol 25 (8) ◽  
pp. 1308-1312 ◽  
Author(s):  
N. Mitsuhashi ◽  
T. Onuma ◽  
S. Kubo ◽  
N. Takayanagi ◽  
M. Honda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document